Position in TGTX
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$325,959
+$112,822 QoQ
Shares Held
5,933
+0.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 54 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SteelPeak Wealth, LLC holds $29,382,424 across 13 Biotechnology names. TGTX ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,939 | $13,679,844 | |
| 2 | NAGE |
Niagen Bioscience, Inc.
|
3,500,129 | $11,165,411 | |
| 3 | TTRX |
Turn Therapeutics Inc.
|
249,456 | $1,821,028 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
16,000 | $582,560 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,314 | $344,365 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
This page
|
5,933 | $325,959 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
656 | $325,854 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
17,198 | $290,990 |
All Filings in TGTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $325,959 | 5,933 | Shares | Sole | 2026-07-13 | |
| 2025-09-30 | $213,137 | 5,900 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $212,341 | 5,900 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $232,637 | 5,900 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||